Lahore: Members of First National Equities Limited convened for an Extraordinary General Meeting on January 12, 2026, addressing several pivotal resolutions aimed at restructuring the company’s capital and enhancing its investment in a key subsidiary.

The meeting, held in Lahore, began with the approval of the minutes from the Annual General Meeting conducted on October 28, 2025. This was followed by a significant decision under Agenda Item 02, where it was unanimously resolved to alter the face value of each ordinary share from Rupees Ten (Rs.10) to Rupees One (Rs.1). This subdivision increases the total number of shares from 500 million to 5,000 million, with no alteration in shareholder rights and privileges.

The subdivision also affects the Issued, Subscribed, and Paid-up Share Capital, which expands from 267,286,331 shares to 2,672,863,310 shares. The company’s Memorandum and Articles of Association will be amended to reflect these changes.

According to information available from the Pakistan Stock Exchange (PSX), this corporate action is a strategic move in the financial market category, aimed at enhancing liquidity and marketability of the shares.

Concurrently, under Agenda Item 03, the company secured approval to augment its investment in a pharmaceutical subsidiary by PKR 500 million, raising the total investment limit to PKR 1.00 billion. This increment is intended to bolster the subsidiary’s capitalization, working capital, and operational requirements.

The Board of Directors is authorized to execute necessary agreements and take all corporate, legal, and regulatory actions required for these resolutions.